Build **OncoBac AI**—a $90K/year **Healthtech SaaS + wetware + clinical trial platform** that **engineers and deploys single-dose bacterial cancer therapies** via **AI-driven microbiome design, CRISPR-enhanced safety, and real-time patient monitoring**.
Validated on That's Missing platform | Status: Active Opportunity
Market Catalyst & News Trigger
"This frog bacterium wiped out cancer tumors in mice with a single dose"
The Workflow Friction
Oncologists, biotech startups, and patients with colorectal cancer (CRC) and other solid tumors
Problem Summary
Real-world problem signal validation.
One-Shot MVP Builder Blueprint (48 Hours)
{"name":"OncoBac Accelerator","coreFeatures":[{"feature":"Bacterial Design Studio","description":"Cloud-based CRISPR design tool (e.g., 'Enhance *Aeromonas veronii* with IL-15—submit to Benchling')."},{"feature":"Single-Dose Manufacturing","description":"AI-optimized bioreactors (e.g., 'Batch #XYZ: 10K doses in 7 days—99.9% viability')."},{"feature":"Real-Time Patient Monitoring","description":"Wearable patch (e.g., 'Patient #ABC: Tumor shrinkage detected—alert oncologist'). Integrates with Apple HealthKit."},{"feature":"Regulatory Playbook Generator","description":"Auto-generates FDA/EMA submissions (e.g., 'IND Application: 100% complete—submit')."},{"feature":"Commercialization Network","description":"Matchmaking with Big Pharma (e.g., 'Pfizer: $20M upfront for global rights')."}],"monetization":["Licensing fees ($500K/drug candidate)","Milestone payments (up to $50M per FDA approval)","SaaS ($25K/year for biotech labs)"],"coFounderMvp":"Partner with a CRC research hospital (e.g., MD Anderson) to run a 50-patient Phase 1 trial, proving single-dose efficacy in 12 months."}
Recommended Developer Tech Stack
- React
- FastAPI
- PostgreSQL
- Benchling API
- Illumina BaseSpace
- Stripe Connect